ASSIGNMENT AND CONSENT AGREEMENTAssignment and Consent Agreement • November 7th, 2024 • Lomond Therapeutics Holdings, Inc. • Blank checks • California
Contract Type FiledNovember 7th, 2024 Company Industry JurisdictionThis ASSIGNMENT AND CONSENT AGREEMENT entered into as of the December 7, 2023, by and among Lomond Therapeutics, Inc., a Delaware corporation (the “Assignor”) and wholly-owned subsidiary of Assignee (as defined below), Eilean Therapeutics, LLC, a Delaware limited liability company (the “Assignee”), and Eil Therapeutics, Inc., a Delaware corporation and wholly-owned subsidiary of Assignee (the “Lender”).
ASSIGNMENT AND CONSENT AGREEMENTAssignment and Consent Agreement • November 7th, 2024 • Lomond Therapeutics Holdings, Inc. • Blank checks • California
Contract Type FiledNovember 7th, 2024 Company Industry JurisdictionThis ASSIGNMENT AND CONSENT AGREEMENT entered into as of the December 7, 2023, by and among Lomond Therapeutics, Inc., a Delaware corporation (the “Assignor”) and wholly-owned subsidiary of Assignee (as defined below), Eilean Therapeutics, LLC, a Delaware limited liability company (the “Assignee”), and Dinas Therapeutics, Inc., a Delaware corporation and wholly-owned subsidiary of Assignee (the “Lender”).